v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (19,882) $ (10,460)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 172 67
Interest and bank fees 0 30
Change in derivative fair value 9,369 156
Impairment of intangible assets 251 874
Other income (expenses) 0 12
Share-based compensation expense 749 2,594
Shares and warrants issued for consulting services 32 127
Accretion expense on convertible promissory note 126 0
Loss on settlement of convertible promissory note 1,353 0
Loss on shares issued for debt 217 0
Drawdown in shares issued for prepaid services 601 0
Changes in operating assets and liabilities:    
Change in accounts receivable (28) (37)
Change in prepaid expenses and deposits 509 (73)
Change in inventories (37) 0
Change in accounts payable (630) 883
Change in accrued liabilities (952) (341)
Change in deferred revenue (44) 13
Net cash used in operating activities (8,194) (6,155)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Payments to acquire equipment (128) (148)
Product enhancements – intangible asset 0 (267)
Net cash used in investing activities (2,488) (477)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of convertible promissory note, net of transaction costs 2,531 1,955
Proceeds from exercise of warrants 9,088 36
Proceeds from sale of shares, net of issuance costs 0 4,308
Net cash provided by financing activities 11,619 6,299
INCREASE (DECREASE) IN CASH 937 (333)
BALANCE OF CASH AT THE BEGINNING OF YEAR 1,810 2,143
BALANCE OF CASH AT THE END OF YEAR 2,747 1,810
Supplemental cash flow information    
Cash paid for interest 0 11
Cash paid for income taxes 0 0
Non-cash investing and financing activities    
Deemed issuance of shares to former shareholders’ of WaveDancer 0 204
Product enhancements - intangible asset in accounts payable and accrued liabilities 0 206
PPE transferred from inventory 25 0
Deemed dividend on warrant inducement 4,649 0
Conversion of Debt Into Common Stock [Member]    
Non-cash investing and financing activities    
Shares issued for debt 383 39
Shares Issued for Conversion of Promissory Notes [Member]    
Non-cash investing and financing activities    
Shares issued for debt 12,339 0
Shares Issued for Prepaid Services [Member]    
Non-cash investing and financing activities    
Shares issued 0 2,440
New Business Acquisitions [Member]    
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisition of new businesses, net of cash acquired (2,360) 0
Outflow from recapitalization transaction (2,360) 0
The Merger [Member]    
CASH FLOWS FROM INVESTING ACTIVITIES:    
Acquisition of new businesses, net of cash acquired 0 (62)
Outflow from recapitalization transaction 0 (62)
Evoke Neuroscience, Inc. [Member]    
Non-cash investing and financing activities    
Shares issued $ 2,743 $ 0